PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
206 hedge funds and large institutions have $2.79B invested in Portola Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 67 increasing their positions, 66 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12% more call options, than puts
Call options by funds: $98M | Put options by funds: $87.2M
2% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 66
Holders
206
Holding in Top 10
10
Calls
$98M
Puts
$87.2M
Top Buyers
| 1 | +$59.2M | |
| 2 | +$29.5M | |
| 3 | +$29.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$26.4M |
| 5 |
Renaissance Technologies
New York
|
+$21.2M |
Top Sellers
| 1 | -$95.5M | |
| 2 | -$58M | |
| 3 | -$30.5M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$19.4M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$18.5M |